Home » Blog » Health Agency Nominations, Health Policy Changes, and Cancer Treatment Costs

Health Agency Nominations, Health Policy Changes, and Cancer Treatment Costs


IP Blog | Dave Melin | December 4, 2016

BioBlog Weekly oncologyThis week’s BioBlog focuses on Trump’s health agency nominations, cancer treatment costs, expected health insurance company profitability in 2017, and expected health policy changes for the upcoming legislative session.

Medicare Beneficiaries Face High Out-of-Pocket Costs for Cancer Treatment

Johns Hopkins reports that individuals on medicare who don’t have a supplemental plan pay huge out of pocket costs.

Donald Trump Signals Big Health Policy Changes Are Coming

The Wall Street Journal reports that given Trump’s picks for the top health positions it is likely that he plans to have health policy at the forefront.

Healthcare Industry Optimistic about Tom Price, Seema Verma Agency Picks

Donald Trump has nominated Price and Verma as top healthcare agency picks. It is expected that the democrats may try and block Price since he has heavily criticized the affordable care act.

Part B Demo, Other Cancer Policy Priorities Still Pending in Lame Duck Session

Various cancer healthcare policies, including the Part B demo, are still sitting in limbo as congress adjourned for Thanksgiving.

Outlook Negative for Payers in 2017, Fitch Says

According to the Fitch Ratings, insurance companies can expect decreased profitability in 2017.


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *